SANTA BARBARA, Calif., Feb. 21, 2013 /PRNewswire-iReach/ -- Active Life Scientific, Inc. announced today receipt of its first commercial order for its BioDentTM Hfc Reference Point Indenter from a Top 5 Global Pharmaceutical company. Prior to this important sale Active Life has sold BioDent systems worldwide to academic, hospital, and government laboratories for researching how material properties can be utilized in personalized medicine by improving the diagnosis and treatment of diseased and damaged tissues.
BioDent Hfc is a new fundamental component of discovering innovative treatments for bone disorders such as osteoporosis, osteogenesis imperfecta, and bone regeneration studies. BioDent Hfc provides critical information about the contribution of material properties to bone fracture resistence throughout the treatment discovery and development process. Active Life has developed numerous important initial applications for testing tissue samples (ex vivo) and previously impossible longitudinal studies of living animals (in vivo).
In making their purchasing decision Active Life customers have carefully evaluated BioDent Hfc against other material and mechanical testing solutions and found that Active Life's product is the only solution that can deliver material property data in longitudinal in vivo studies, enabling translation of their research into the clinic.
About BioDent™ Reference Point Indenter
Among researchers it is understood that bone strength, a complete measure of bone fracture resistence, depends on three things:
- How much bone material there is (bone mass/bone mineral density),
- How well the bone material is put together (bone structure), and
- How good that bone material is (bone material properties)
The BioDent Hfc Reference Point Indenter provides researchers with previously impossible means to assess the material properties of bone that resides in a living body (in vivo).
About Active Life Scientific, Inc.
Active Life Scientific, Inc. develops life science research and diagnostic tools with the unrivaled ability to quantify the quality of tissues that reside inside the living body. Biological tissue quality is an important measure of health currently practiced through qualitative manual palpation and more commonly known as how fibrous, elastic, or strong a tissue is. The Company's products are based on world renowned inventor Dr. Paul Hansma's latest breakthrough, Reference Point Indentation.
Active Life's flagship product, BioDent™, is utilized by researchers who investigate diseased tissues and related treatments. The Company initially supports bone research and is quickly expanding applications for other tissues. Active Life's mission is to become the leading, worldwide provider of life science research and diagnostic tools that quantify tissue quality to enable accelerated drug development, cost-effective health care, and a better quality of life.
Davis Brimer, Active Life Scientific, Inc., +1.805.770.2600 x101, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Active Life Scientific, Inc.